Skip to content

To compare the effect of no choice and choice-based training in arm non-use condition.

: Investigations on short term reversal of simulated arm non-use in healthy subjects with monetary rewards.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028404
Enrollment
30
Registered
2020-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: RIMT: Reinforcement induced movement therapy Duration will be 30 mins Control Intervention1: CIMT: Constraint induced movement therapy Duration will be 30 mins

Sponsors

Ann David
Lead Sponsor
Dr Anju Kuruvilla
Collaborator
Dr Sivakumar Balasubramanian
Collaborator
Dr Varadhan SKM
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. No previous history of upper limb impairment due to neurological conditions 2. Willing to give informed consent

Exclusion criteria

Exclusion criteria: Edinburgh handedness score less than 60.

Design outcomes

Secondary

MeasureTime frame
Feedback questionnaire: o Awareness of perturbation in induced LNU phase o Use of explicit strategy in the intervention phase o Awareness of visuomotor rotation in the post-intervention phase o Confidence in using the right arm in the post-intervention phase.Timepoint: End of trial;Success rate at the end of each block for left and right handTimepoint: End of trial

Primary

MeasureTime frame
The primary outcome will be the change in probability of right arm use across each block. The difference in the probability of right use will be analyzed in the post-intervention phase for CIMT and RIMT group.Timepoint: Post intervention phase

Countries

India

Contacts

Public ContactAnn David

Christian Medical College, Vellore

siva82kb@cmcvellore.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026